Trials / Conditions / Antithrombin III Deficiency
Antithrombin III Deficiency
7 registered clinical trials studyying Antithrombin III Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Belgian Antithrombin Deficiency Registry NCT05891899 | Universitair Ziekenhuis Brussel | — |
| Terminated | Antithrombin III in Infectious Disease Caused by COVID-19 NCT04899232 | Enrique Ginzburg | Phase 2 |
| Completed | Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO NCT04879550 | Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital | — |
| Withdrawn | Atenativ Effect on Uterine Blood Flow and Preeclampsia NCT02278575 | Vastra Gotaland Region | Phase 4 |
| Unknown | "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defect NCT02503267 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Active Not Recruiting | Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate NCT00319228 | Grifols Biologicals, LLC | Phase 2 / Phase 3 |
| Completed | Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery o NCT00110513 | rEVO Biologics | Phase 3 |